// App-Quantinova.ai

4517 : Avelumab as the basis of neoadjuvant regimen in platinum-eligible and -ineligible patients with nonmetastatic muscle-invasive bladder cancer AURA (Oncodistinct-004) trial.

Researchers

Presenter

  • Nieves Martinez Chanza

Principal Investigators

  • Philippe Barthélémy

  • Vinciane Casert

  • Lionel Staudacher

  • Jan Van Den Brande

  • Brieuc Sautois

  • Vincent Vanhaudenarde

  • Emmanuel Seront

  • Veronique Debien

  • Thierry Gil

  • Marianne Paesmans

  • Nuria Kotecki

  • Michail Ignatiadis

  • Simone Albisinni

  • Jean Christophe Fantoni

  • Thibault Tricard

  • Romain Diamond

  • Thierry Andre Roumeguere

  • Ahmad Awada

Medical Centers

  • Medical Oncology Department, Jules Bordet Institute, Université Libre de Bruxelles, Brussels, Belgium

  • Centre Oscar Lambret, Lille, France

  • Institut de Cancérologie Strasbourg Europe,Strasbourg, France, Strasbourg, France

  • Centre Hospitalier Universitaire Ambroise Pare, Mons, Belgium

  • Groupe Hospitalier Paris Saint Joseph, Paris, France

  • University Hospital Antwerp, Edegem, Antwerp, Belgium

  • University Hospital of Liège, CHU Sart-Tilman, Liège, Belgium

  • Clinique et Maternite Saint Elisabeth, Namur, Belgium

  • Institut Roi Albert II, Department of Medical Oncology, Saint Luc University Hospital, Brussels, Belgium

  • Academic Trials Promoting Team, Institut Jules Bordet and l’Université Libre de Bruxelles (U.L.B), Brussels, Belgium

  • Institute Jules Bordet, Brussels, Belgium

  • Data Centre, Institut Jules Bordet - Universite Libre de Bruxelles (ULB), Brussels, Belgium

  • Institute Jules Bordet, Brussels, Belgium

  • Hopital Erasme- universite Libre de Bruxelles, Brussels, Belgium

  • Institut de Cancérologie Strasbourg Europe,Strasbourg, France, Strasbourg, France

  • Jules Bordet Institute, Bruxelles, Belgium

  • Erasme Hospital, University Clinics of Brussels, Brussels, Belgium

  • Medical Oncology Department, Institut Jules Bordet and l'Université Libre de Bruxelles, Brussels, Belgium

Locations

  • Belgium

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

  • Solid malignancies

Biomarkers

  • Aurora kinase A

Drug/Treatment

  • Gemcitabine

  • Paclitaxel

  • Cisplatin

  • Avelumab

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Prospective

Phase

  • II

Study Id's

  • NCT03674424

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved